Exane Derivatives’s Invensense Inc INVN Stock Holding History

Exane Derivatives’s Portfolio INVN Stock Details INVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-192	Closed	-$2.42K	–	694
2017 Q1	$2.42K	Sell	192 -3,021	-94%	-$37.6K	﹤0.01%	390
2016 Q4	$41.1K	Sell	3,213 -413	-11%	-$3.53K	0.01%	308
2016 Q3	$26.9K	Sell	3,626 -1,858	-34%	-$13.2K	﹤0.01%	341
2016 Q2	$33.6K	Buy	5,484 +1,248	+29%	+$8.62K	0.01%	301
2016 Q1	$35.6K	Buy	+4,236	New	+$33.6K	﹤0.01%	344
2015 Q3	–	Sell	-1,341	Closed	-$20.2K	–	581
2015 Q2	$20.2K	Hold	1,341	–	–	﹤0.01%	341
2015 Q1	$20.4K	Sell	1,341 -276	-17%	-$4.35K	﹤0.01%	359
2014 Q4	$26.3K	Buy	+1,617	New	+$27.1K	﹤0.01%	373

Exane Derivatives's INVN Position: Q2 2017 in Review

Exane Derivatives sold out of Invensense Inc (INVN) in Q2 2017, closing a stake of 192 shares — an estimated $2.42K sold.

Exane Derivatives first reported a position in INVN in Q4 2014 and held it in 8 quarters. The position peaked at $41.1K in Q4 2016. 0 funds tracked by Wall St. Rank hold INVN as of Q2 2017.

Exane Derivatives reported no remaining Invensense Inc position as of Q2 2017 after selling out during the quarter.
Exane Derivatives sold 192 Invensense Inc shares in Q2 2017, an estimated $2.42K.
Exane Derivatives first reported a position in Invensense Inc in Q4 2014 and held it in 8 quarters.
Exane Derivatives's Invensense Inc position peaked at $41.1K in Q4 2016.
0 funds tracked by Wall St. Rank held Invensense Inc as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.